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ABSTRACT
Understanding protein subcellular localization is important to determining the
functional role of specific proteins. T-cell protein tyrosine phosphatase (TC-PTP)
contains bipartite nuclear localization signals (NLSI and NLSII) in its C-terminus.
We previously have demonstrated that the nuclear form of TC-PTP (TC45) is mainly
localized to the cytoplasm in keratinocytes and it is translocated to the nucleus
following UVB irradiation. Here, we report that TC45 is translocated by an AKT/14-33σ-mediated mechanism in response to UVB exposure, resulting in increased apoptosis
and decreased keratinocyte proliferation. We demonstrate that UVB irradiation
increased phosphorylation of AKT and induced nuclear translocation of 14-3-3σ and
TC45. However, inhibition of AKT blocked nuclear translocation of TC45 and 14-33σ. Site-directed mutagenesis of 14-3-3σ binding sites within TC45 showed that a
substitution at Threonine 179 (TC45/T179A) effectively blocked UVB-induced nuclear
translocation of ectopic TC45 due to the disruption of the direct binding between TC45
and 14-3-3σ. Overexpression of TC45/T179A in keratinocytes resulted in a decrease of
UVB-induced apoptosis which corresponded to an increase in nuclear phosphorylated
STAT3, and cell proliferation was higher in TC45/T179A-overexpressing keratinocytes
compared to control keratinocytes following UVB irradiation. Furthermore, deletion
of TC45 NLSII blocked its UVB-induced nuclear translocation, indicating that both
T179 and NLSII are required. Taken together, our findings suggest that AKT and 143-3σ cooperatively regulate TC45 nuclear translocation in a critical step of an early
protective mechanism against UVB exposure that signals the deactivation of STAT3
in order to promote keratinocyte cell death and inhibit keratinocyte proliferation.

INTRODUCTION

and activator of transcription 1 (STAT1), STAT3, and
STAT5, which suggests that TC-PTP negatively regulates
the JAK/STAT signaling, an important mechanism for
the transmission of extracellular signals that can regulate
proliferation, differentiation, and apoptosis [3, 4]. Studies
performed using TC-PTP knockout mice showed its
critical role in hematopoiesis and immune function
because TC-PTP knockout mice were severely defective
in the hematopoietic compartment and all homozygous

T-cell protein tyrosine phosphatase, or TC-PTP,
(encoded by PTPN2) is one of 17 intracellular, nonreceptor PTPs that is ubiquitously expressed in embryonic
and adult tissues, however high abundance is observed in
hematopoietic tissues [1, 2]. TC-PTP has been shown to
have a variety of functions. Substrates targeted by TC-PTP
include Janus kinase 1 (JAK1), JAK3, signal transducer
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mice died between 3 and 5 weeks of age due to diarrhea,
splenomegaly, lymphadenopathy, and anemia [5]. TCPTP is also involved in the regulation of the cell cycle
[6-8]. Furthermore, TC-PTP has a role in the regulation
of diabetes and obesity by modulating insulin and leptin
signaling [9-12]. In terms of cancer, recent studies
revealed a focal deletion of PTPN2 in human T-cell acute
lymphoblastic leukemia, implying the potential role of
TC-PTP as a tumor suppressor [13]. Studies also have
shown that TC-PTP can suppress tumor growth by downregulating STAT3 signaling in several types of cancers
including breast cancer and colon cancer [14, 15].
Our previous studies using epidermal specific
TC-PTP knockout mice indicated that TC-PTP can play
a role in attenuating chemically-induced skin cancer
formation by negatively regulating STAT3 and AKT
signaling [16]. TC-PTP deficiency in mouse epidermis
led to a significant decrease in apoptosis induced by the
carcinogen 7,12-dimethylbenz [a]anthracene (DMBA)
and a significant increase in epidermal thickness and
hyperproliferation following treatment with the tumor
promotor 12-O-tetradecanoylphorbol-13-acetate (TPA).
TC-PTP knockout mice showed a shortened latency
of tumorigenesis and significantly increased tumor
development during DMBA/TPA skin carcinogenesis
compared to control mice. Papillomas formed on TC-PTP
knockout mice during carcinogenesis exhibited higher
levels of phosphorylated STAT3 and phosphorylated AKT
when compared with control [16].
In addition, TC-PTP is involved in the rapid
dephosphorylation of STAT3 in keratinocytes which is
induced by UVB irradiation. Knockdown of TC-PTP
in keratinocytes resulted in a significantly higher level
of phosphorylated STAT3 in the absence or presence of
UVB compared with control keratinocytes [17]. Further
studies revealed that TC-PTP is activated in response
to UVB irradiation, which can lead to suppression of
keratinocyte survival and proliferation through the downregulation of STAT3 signaling. TC-PTP deficiency in
keratinocytes increased cell proliferation and decreased
apoptosis after exposure to UVB which corresponded
with increased levels of phosphorylated STAT3. Similarly,
overexpression of TC-PTP in keratinocytes led to a
significant decrease in cell proliferation with a decrease
in the level of phosphorylated STAT3 following UVB
irradiation [18], suggesting a critical role for TC-PTP in
the STAT3-dependent regulation of keratinocyte survival
and proliferation.
There are two forms of TC-PTP generated by
alternative splicing at the 3’ end of the gene: TC45 (TCPTPa) and TC48 (TC-PTPb). The different C-termini
of the isoforms determine substrate specificity and
subcellular localization. TC45 (45 kDa) is the major form
of TC-PTP in most species including human and mouse.
TC45 contains a bipartite nuclear localization signal (NLS)
and is found primarily in the nucleus, while TC48 (48
www.impactjournals.com/oncotarget

kDa) contains a hydrophobic C-terminus and is localized
to the endoplasmic reticulum. [19-21]. However, our
previous studies showed that TC45 is primarily localized
in the cytoplasm of keratinocytes and then is translocated
from the cytoplasm to the nucleus in response to UVB
irradiation [17]. In the current study, we report a novel
mechanism by which TC45 nuclear translocation occurs
in keratinocytes via AKT/14-3-3σ-mediated signaling
and we describe its effects on keratinocyte survival and
proliferation upon exposure to UVB.

RESULTS
UVB-induced AKT activation triggers nuclear
translocation of TC45 in keratinocytes
Although TC45 has previously been reported to be
mainly localized in the cell nucleus due to its bipartite
nuclear localization signal (NLS), our recent studies
indicated that TC45 is predominantly localized in the
cytoplasm of skin keratinocytes and it is translocated
to the nucleus following UVB exposure, suggesting
there is a skin specific mechanism of TC45 nuclear
translocation [17]. To identify the mechanism whereby
UVB irradiation triggers nuclear translocation of TC45
in keratinocytes, mouse primary keratinocytes were
exposed to three different doses of UVB (50, 100, or
150 mJ/cm2) and the levels of TC45 and phosphorylated
STAT3 were determined in both nuclear and cytoplasmic
lysates. Following UVB irradiation, TC45 was rapidly
translocated to the nucleus in a dose- and time-dependent
manner (Figure 1A). The level of phosphorylated STAT3
was decreased in correlation with the increase in TC45
nuclear translocation. Similarly, the level of cytoplasmic
TC45 was decreased with its nuclear translocation
following UVB irradiation in a dose- and time-dependent
manner (Figure 1B). The level of phosphorylated STAT3
was rapidly reduced in the cytoplasm of keratinocytes
following UVB exposure as previously observed [17]. To
verify that UVB radiation stimulates transport of TC45 to
the nucleus rather than up-regulating TC45 expression,
primary keratinocytes were pretreated with cycloheximide,
a protein synthesis inhibitor, before UVB irradiation.
Cycloheximide had no effect on TC45 expression even in
the presence of UVB irradiation (Supplementary Figure
1).
It is possible that TC45 may interact with other
cytoplasmic proteins in order for it to undergo nuclear
translocation. Based on this hypothesis, we searched
protein-protein interaction motifs within TC45 using
Scansite (http://scansite3.mit.edu) to find a protein(s)
that could be involved in the process of TC45 nuclear
translocation. This search revealed that TC45 contains
three putative 14-3-3 binding sites (S173, T179, and
90675
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Figure 1: AKT regulates UVB-mediated nuclear translocation of TC45 in keratinocytes. A. and B. Mouse primary

keratinocytes were cultured and irradiated with UVB at three doses: 50, 100, or 150 mJ/cm2. Cells were collected at the indicated times after
UVB exposure. Nuclear and cytoplasmic lysates were separately extracted. A. Western blot analysis of nuclear TC45 and phosphorylated
STAT3 (pSTAT3) after UVB irradiation in keratinocytes. C: cytoplasmic fraction, no UVB irradiation. Lamin A/C was used as a control for
nuclear fraction. B. Western blot analysis of cytoplasmic TC45 and pSTAT3 after UVB irradiation in keratinocytes. N: nuclear fraction, no
UVB irradiation. LDH was used as a control for cytoplasmic fraction. C. Schematic representation of putative interaction motifs for 14-3-3
within the TC45 amino acid sequence identified by Scansite3 (http://scansite3.mit.edu). D. Western blot analysis of phosphorylated AKT
(pAKT), AKT, phosphorylated AKT substrate, or 14-3-3σ in response to UVB irradiation. 3PC keratinocytes were cultured and irradiated
with UVB at a dose of 100 mJ/cm2. Cells were collected at the indicated times. E. Western blot analysis of nuclear TC45 in response to
UVB irradiation. Cells were cultured and treated with AKT1/2 inhibitor (1 μM), Staurosporine (10 nM), Gö6983 (1 μM), RO-31-8220 (3
μM), or Gö6976 (1 μM) for 1 h before UVB irradiation (100 mJ/cm2, lanes 2-8). For activation of TC45 (lane 8), cells were treated with
spermidine (0.2 μM), a known TC-PTP activator, for 1 h before UVB irradiation. Cells were then collected 3 h after UVB irradiation and
nuclear lysates were isolated.
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T225) (Figure 1C). The 14-3-3 proteins are a family of
evolutionarily conserved regulatory chaperone molecules
involved in many physiological functions including
signal transduction, stress response, apoptosis, and cell
cycle checkpoint regulation and they function mainly
by interacting with phosphoproteins containing the
consensus motif RX(Y/F)XpS/TXP or RSXpS/TXP,

where X represents any amino acid and pS/T represents
phosphoserine and phosphothreonine, respectively [2224]. In mammals, there are seven isoforms of 14-3-3
protein: β, ε, γ, ζ, η, σ, and τ. Most of the 14-3-3 isoforms
are widely expressed in various tissues, however, 14-33σ is only expressed in epithelial cells [25]. 14-3-3 plays
a role in a variety of cellular responses as a regulator

Figure 2: AKT cooperates with 14-3-3σ to facilitate nuclear translocation of TC45 in response to UVB irradiation.

Western blot analysis of A. cytoplasmic and B. nuclear 14-3-3σ in response to UVB irradiation. 3PC keratinocytes were cultured and
irradiated with UVB at a dose of 100 mJ/cm2. Cells were collected at the indicated times after UVB exposure. Nuclear and cytoplasmic
lysates were separately extracted. C: cytoplasmic fraction, no UVB irradiation. N: nuclear fraction, no UVB irradiation. C. 3PC keratinocytes
overexpressing TC45/WT were cultured and transfected with control or 14-3-3σ-specific siRNA. Cells were collected 3 h after UVB
irradiation (100 mJ/cm2). Nuclear and cytoplasmic fractions were isolated and resolved by SDS-PAGE and immunoblotted with antibodies
specific for V5 to detect exogenous TC45, 14-3-3σ, β-actin, or Lamin A/C. D. 3PC keratinocytes overexpressing TC45/WT were treated
with Leptomycin B (LMB) or DMSO for 1 h before UVB irradiation (100 mJ/cm2). Cells were collected 3 h after UVB irradiation. Nuclear
fractions were isolated and resolved by SDS-PAGE and immunoblotted with antibodies specific for V5 or 14-3-3σ. Western blot analysis
of E. nuclear pAKT and 14-3-3σ and F. cytoplasmic pAKT and 14-3-3σ. 3PC keratinocytes overexpressing TC45/WT were incubated with
AKT1/2 inhibitor for 1 h before UVB exposure (100 mJ/cm2) and then cells were incubated with inhibitor again for 3 h following UVB
irradiation at which time nuclear and cytoplasmic fractions were extracted.
www.impactjournals.com/oncotarget
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of the subcellular localization of interacting proteins
[25, 26]. AKT is one kinase capable of phosphorylating
the 14-3-3 binding motifs of various target proteins
including p27Kip1, FoxO3, and Notch5, and regulating
their nucleocytoplasmic transport [27-29]. Therefore, we
examined the levels of phosphorylated (active) AKT and
14-3-3σ following UVB irradiation of the 3PC mouse
keratinocyte cell line, an immortalized cell line derived
from DMBA-altered adult mouse primary keratinocytes
which has been extensively utilized in our previous
studies [16-18]. The level of AKT phosphorylation in
keratinocytes gradually increased over time in response
to UVB irradiation, which correlated with a subsequent
increase in phosphorylated AKT substrate 30 minutes
after exposure (Figure 1D, see also Supplementary Figure
2). 14-3-3σ was constitutively expressed in keratinocytes
independent of UVB irradiation. To investigate whether
AKT is involved in UVB-induced nuclear translocation
of TC45, keratinocytes were pretreated with different
inhibitors that either inhibit AKT activation (AKT1/2) or
inhibit Protein Kinase C (Staurosporine, Gӧ6983, RO-318220 or Gӧ6976), a negative regulator of AKT signaling
[30, 31]. As shown in Figure 1E, only AKT1/2 inhibitor
blocked TC45 nuclear translocation after UVB irradiation
as evidenced by the decrease in nuclear TC45 expression
to a level similar to untreated control. In addition,
spermidine, a known activator of TC-PTP, appeared to
further increase the level of nuclear TC45 after UVB
irradiation in comparison to UVB treatment alone
(Figure 1E). These results suggest that AKT activation is
important to the nuclear translocation of TC45 following
UVB irradiation which is critical to TC45 regulation.

the nucleus [32]. In agreement with this observation,
pretreatment with Leptomycin B (LMB), an inhibitor
of nuclear export, further increased the level of nuclear
14-3-3σ in keratinocytes following UVB irradiation
compared to untreated keratinocytes (Figure 2D).
Similarly, pretreatment of keratinocytes with LMB also
further increased the level of nuclear TC45 in response to
UVB irradiation compared to untreated controls (Figure
2D), indicating TC45 can shuttle between the cytoplasm
and the nucleus like 14-3-3σ. We also examined whether
AKT phosphorylation is involved in 14-3-3σ nuclear
translocation after UVB irradiation. As shown in Figure
2E and 2F, pretreatment of keratinocytes with AKT1/2
inhibitor blocked 14-3-3σ nuclear translocation in
response to UVB irradiation. Collectively, these results
suggest that TC45 nuclear translocation in keratinocytes
is mediated by an AKT/14-3-3σ axis in response to UVB
irradiation.

Mutation at T179 within TC45 prevents its
nuclear translocation in keratinocytes following
UVB irradiation
As previously mentioned, TC45 contains three
putative sites within its catalytic domain that are
recognized as 14-3-3σ binding sites: S173, T179, and
T225. To examine whether or not these sites are important
for TC45 nuclear translocation, each amino acid was
mutated to alanine (A) by site-directed mutagenesis
(Figure 3A). Then, stable 3PC keratinocyte cell lines that
overexpress each of the three mutants (S173A, T179A, or
T225A) with a V5 epitope tag were generated by lentiviral
transduction. Following UVB exposure, exogenous wildtype TC45 (TC45/WT) and exogenous mutants TC45/
S173A and TC45/T225A underwent nuclear translocation
as detected by an anti-V5-tag antibody (Figure 3B, 3C,
and 3E, respectively). However, TC45/T179A was not
translocated to the nucleus in response to UVB irradiation
(Figure 3D). Immunofluorescent analysis clearly showed
that while exogenous TC45/WT was mainly localized
in the cytoplasm and then translocated to the nucleus
in response to UVB irradiation (Figure 3F), exogenous
TC45/T179A was primarily localized in the cytoplasm
even after UVB irradiation (Figure 3G). As previously
discussed, our data showed that TC45 can be prevented
from shuttling between the cytoplasm and the nucleus
by treatment with LMB (Figure 2D). In contrast to this
result, the level of nuclear TC45/T179A was not increased
in keratinocytes pretreated with LMB and irradiated with
UVB (Supplementary Figure 3).
Amino acid sequence alignment of mouse TC45
with human TC45 indicates that mouse TC45 has 90%
sequence identity with human TC45 and the three putative
14-3-3σ binding sites are conserved in the TC45 catalytic
domain of both species (Supplementary Figure 4). To

AKT/14-3-3σ axis is required for UVB-induced
TC45 nuclear translocation in keratinocytes
As shown in Figure 1D, the level of 14-3-3σ
expression in keratinocytes was unaffected by UVB
irradiation. 14-3-3σ is an important regulatory protein
with a significant number of interacting proteins that has
been reported to be primarily localized in the cytoplasm
of eukaryotic cells, such as U-2 OS osteosarcoma cells
[32]. Therefore, we wished to confirm the subcellular
localization of 14-3-3σ in keratinocytes. 14-3-3σ was
primarily localized to the cytoplasm of keratinocytes
(Figure 2A). Following UVB irradiation, a proportion
of 14-3-3σ underwent nuclear translocation in a dosedependent manner (Figure 2B), which is similar to the
results for TC45 (Figure 1A). To investigate whether 143-3σ is involved in the nuclear translocation of TC45,
RNAi was used to knockdown 14-3-3σ in our previously
established TC45/WT-overexpressing keratinocyte cell
line [18]. Knockdown of 14-3-3σ prevented TC45 nuclear
translocation following UVB irradiation (Figure 2C).
14-3-3σ is known to shuttle between the cytoplasm and
www.impactjournals.com/oncotarget
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Figure 3: Amino acid residue Threonine 179 is required for TC45 nuclear translocation. A. Schematic representation of

site-directed mutagenesis of three putative 14-3-3σ binding sites located in the PTP catalytic domain of TC45. Serine residue at position 173
and threonine residues at positions 179 and 225 were substituted with alanine: S173A, T179A, and T225A, respectively. B.- E. Western blot
analysis of nuclear TC45 in response to UVB irradiation. 3PC keratinocyte cells overexpressing B. TC45/WT, C. TC45/S173A, D. TC45/
T179A, or E. TC45/T225A were cultured and irradiated with UVB at a dose of 100 mJ/cm2. Nuclear fractions were isolated 3 h after UVB
irradiation. Exogenous TC45 expression was detected using an anti-V5 antibody. F. and G. Representative images of immunofluorescence
analysis of nuclear translocation of TC45 following UVB irradiation. Keratinocytes overexpressing either F. TC45/WT or G. TC45/T179A
were cultured and irradiated with UVB at a dose of 100 mJ/cm2. Cells were cultured for 3 h after UVB exposure and then subjected to
immunofluorescence analysis by using an anti-V5 antibody to detect exogenous TC45 expression. Cells untreated with UVB were utilized
as control (Sham). Scale bar: 20 μm.
www.impactjournals.com/oncotarget
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examine the nuclear translocation of human TC45 (hTC45)
in keratinocytes following UVB irradiation, stable human
HaCaT keratinocyte cell lines that overexpress either
exogenous hTC45/WT or hTC45/T179A were generated
by lentiviral transduction. Similar with mouse wild-type
TC45, exogenous hTC45/WT was translocated from the
cytoplasm to the nucleus after UVB irradiation. However,
exogenous hTC45/T179A was not translocated to the
nucleus following UVB irradiation (Supplementary Figure
5A). To confirm the involvement of 14-3-3σ in the nuclear
translocation of hTC45 following UVB irradiation,
RNAi was used to knockdown expression of 14-3-3σ in
hTC45/WT-overexpressing HaCaT keratinocytes. Again,
similar to results with mouse TC45, knockdown of 143-3σ resulted in the loss of exogenous hTC45 nuclear
translocation following UVB irradiation (Supplementary
Figure 5B). Combined, these results provide strong
evidence that T179 is required for the UVB-induced
nuclear translocation of TC45.

in TC45/WT-expressing keratinocytes compared to
control keratinocytes after UVB irradiation, whereas
its expression level was increased in TC45/T179Aoverexpressing keratinocytes compared to control
keratinocytes in response to UVB (Figure 4E).

Disruption of NLS II in TC45 prevents UVBmediated nuclear translocation
Human TC45 contains a NLS in its C-terminus and
consequently it is localized to the nucleus of other types
of cells. Human TC45 NLS is bipartite and contains basic
cluster I (residues 350-358, NLS I) and basic cluster II
(residues 377-381, NLS II) [33]. It is reported that importin
β, an essential factor required for nuclear transport of
NLS-containing proteins, interacts with the NLSII of
human TC45 and is necessary for nuclear import of TC45
[34]. In mouse, both NLS I (residues 345-353) and NLS
II (residues 372-376) are conserved in its C-terminus
[19] (See Supplementary Figure 3). To examine whether
either TC45 NLS is involved in UVB-induced nuclear
translocation in keratinocytes, we generated two NLS
mutants of TC45 (Figure 5A). In the NLS I mutation
(named TC45/R345Q), three basic residues (R345, K346,
R347) were substituted with glutamine (Q). In the NLS
II mutation (named TC45/Δ372), five residues (372-376)
were deleted (Δ). We then established stable keratinocyte
cell lines that overexpress either TC45/R345Q or TC45/
Δ372 by lentiviral transduction. The NLS I mutation
did not have an effect on UVB-induced TC45 nuclear
translocation (Figure 5B). However, the NLS II mutation
of TC45 blocked its nuclear translocation in response to
UVB (Figure 5C). Immunofluorescent analysis clearly
showed that TC45/Δ372 is exclusively localized to the
cytoplasm of TC45/Δ372-overexpressing keratinocytes in
the absence or presence of UVB irradiation (Figure 5D),
indicating that NLS II, along with the T179-containing
14-3-3σ binding motif, is required for efficient nuclear
translocation of TC45. Consistent with previous results,
the level of phosphorylated STAT3 was visibly higher in
TC45/Δ372-overexpressing keratinocytes compared to
either control or TC45/WT-overexpressing keratinocytes
after UVB irradiation (Figure 5E).
As previously mentioned, TC48 contains a
hydrophobic region in its C-terminus and thereby is
localized to the endoplasmic reticulum (Figure 5A).
The PTP catalytic domain of TC48 is identical with that
of TC45 so TC48 also contains three putative 14-3-3σ
binding sites. To investigate whether TC48 is translocated
to the nucleus following UVB irradiation like TC45, we
cloned mouse TC48 with V5 epitope tag and generated
a stable 3PC keratinocyte cell line that overexpresses it
by lentiviral transduction. TC48 was detected by anti-V5
antibody, but it was not detected by TC45-specific
antibody (Figure 5F). TC48 was primarily localized in the

TC45 directly interacts with 14-3-3σ in
keratinocytes in response to UVB irradiation
Our results suggest that in order for TC45 to undergo
nuclear translocation following UVB irradiation, AKT
phosphorylates TC45, allowing TC45 to interact with 14-33σ through this active site. To confirm the UVB-mediated
interaction of TC45 with 14-3-3σ in keratinocytes,
exogenous TC45 was immunoprecipitated with an anti-V5
antibody from TC45/WT- or TC45/T179A-overexpressing
3PC cells and probed with either an anti-14-3-3σ or antiSTAT3 antibody. As shown in Figure 4A and 4B, TC45/
WT interacted with 14-3-3σ following UVB irradiation,
whereas TC45/T179A could not. Furthermore, TC45/WT
interacted with its target STAT3 in the absence or presence
of UVB irradiation. Interestingly, this interaction was not
detected in TC45/T179A-overexpressing cells (Figure
4A, 4B). Then, we examined the subcellular localization
of 14-3-3σ in TC45/T179A-overexpressing cells after
UVB irradiation. Expression of 14-3-3σ was not detected
in the nucleus of TC45/T179A-overexpressing cells in
the absence or presence of UVB irradiation (Figure 4C).
Immunofluorescent analysis also clearly demonstrated
that while 14-3-3σ was mainly localized in cytoplasm,
like TC45/WT, it is translocated to the nucleus of
TC45-expressing cells in response to UVB irradiation.
However, 14-3-3σ remained localized to the cytoplasm
of TC45/T179A-overexpressing cells even after UVB
irradiation (Figure 4D), confirming that TC45 nuclear
translocation is associated with 14-3-3σ. Additionally, our
data demonstrating that STAT3 interacts with TC45/WT
but not with TC45/T179A implies nuclear translocation
of TC45 is critical for STAT3 dephosphorylation after
UVB irradiation. Correspondingly, western blot analysis
showed the level of phosphorylated STAT3 was reduced
www.impactjournals.com/oncotarget
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Figure 4: 14-3-3σ transports TC45 into the keratinocyte nucleus following UVB irradiation through direct binding.

3PC keratinocytes overexpressing A. TC45/WT or B. TC45/T179A were cultured and irradiated with UVB at a dose of 100 mJ/cm2.
Cells were collected at the indicated times after UVB irradiation. Total cell lysates were subjected to immunoprecipitation with anti-V5
antibody and resolved by SDS-PAGE and immunoblotted with antibodies specific for 14-3-3σ, STAT3, or V5 (TC45). C. Western blot
analysis of 14-3-3σ in response to UVB irradiation. 3PC keratinocytes overexpressing TC45/T179A were cultured and irradiated with
UVB at a dose of 100 mJ/cm2. Cells were collected 3 h after UVB irradiation. Nuclear and cytoplasmic lysates were separately extracted.
D. Representative images of immunofluorescence analysis of 14-3-3σ and TC45 following UVB irradiation. Keratinocytes overexpressing
TC45/T179A were cultured and irradiated with UVB at a dose of 100 mJ/cm2. After 3 h of UVB irradiation, keratinocytes were subjected
to immunofluorescence analysis by using an anti-V5 antibody to detect exogenous TC45 expression and an anti-14-3-3σ antibody. Scale
bar: 20 μm. E. Western blot analysis of pSTAT3 in response to UVB irradiation. 3PC keratinocytes overexpressing TC45/WT or TC45/
T179A were cultured and irradiated with UVB at a dose of 100 mJ/cm2. Cells were collected 3 h after UVB irradiation. Total cell lysates
were then extracted.
www.impactjournals.com/oncotarget
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Figure 5: Disruption of NLSII in TC45 prevents UVB-induced nuclear translocation in keratinocytes. A. Schematic

representations of two NLS mutations, R345Q:K346Q:R347Q for NLS I and Δ372-376 for NLS II, located in the C-terminal domain
of TC45 and TC48, the cytoplasmic isoform of TC-PTP. Three residues at position 345-347 were substituted with glutamine (TC45/
R345Q). Five residues at positions 372-376 were deleted (TC45/Δ372). B. and C. Western blot analysis of nuclear TC45 in response
to UVB irradiation. 3PC keratinocyte cells overexpressing B. TC45/R345Q or C. TC45/Δ372 were cultured and irradiated with UVB
at a dose of 100 mJ/cm2. Nuclear fractions were isolated 3 h after UVB irradiation. Exogenous TC45 expression was detected using an
anti-V5 antibody. D. Representative images of immunofluorescence analysis of TC45/Δ372 following UVB irradiation. Keratinocytes
overexpressing TC45/Δ372 were cultured and irradiated with UVB at a dose of 100 mJ/cm2. After 3 h of UVB irradiation, keratinocytes
were subjected to immunofluorescence analysis by using an anti-V5 antibody to detect exogenous TC45 expression. Cells untreated with
UVB were utilized as control (Sham). Scale bar: 20 μm. E. Western blot analysis of pSTAT3 expression in response to UVB irradiation.
3PC keratinocytes overexpressing TC45/WT or TC45/Δ372 were cultured and irradiated with UVB at a dose of 100 mJ/cm2. Cells were
collected 3 h after UVB irradiation. Total cell lysates were then extracted. F. Stable overexpression of TC45 or TC48 in keratinocytes. 3PC
keratinocytes overexpressing TC45 or TC48 were cultured and total cell lysates were extracted. TC45 expression was detected using either
an anti-V5 antibody (exogenous) or an anti-TC45 antibody (endogenous). Exogenous TC48 expression was detected using an anti-V5
antibody. G. 3PC keratinocytes overexpressing TC48 were cultured and irradiated with UVB at a dose of 100 mJ/cm2. Cells were collected
3 h after UVB irradiation and then nuclear and cytoplasmic lysates were isolated and immunoblotted with an antibody specific for V5 to
detect exogenous TC48. H. Western blot analysis of pSTAT3 expression. 3PC keratinocytes overexpressing TC45 or TC48 were cultured
Cells were collected and total cell lysates were then extracted.
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cytoplasm and UVB irradiation did not have an effect on
its subcellular localization (Figure 5G). Consistent with
these results, the level of phosphorylated STAT3 was very
high in TC48-overexpressing keratinocytes compared to
either control or TC45/WT-overexpressing keratinocytes
after UVB irradiation (Figure 5H), further confirming
that nuclear translocation of TC45 is required for STAT3
dephosphorylation after UVB irradiation.

cleaved PARP were increased in TC45/WT-overexpressing
cells compared to TC45/T179A-overexpressing cells
in response to UVB (Figure 6D). We further examined
the impact of TC45 nuclear translocation on UVBinduced apoptosis by analyzing the cell cycle using flow
cytometry. Following UVB irradiation, the percentage of
TC45/WT-overexpressing cells in the sub G1 phase (i.e.
cells undergoing apoptosis) was much higher compared to
TC45/T179A-overexpressing cells (Figure 6E). Together,
these results suggest that TC45 translocation to the nucleus
is a critical step in the dephosphorylation of STAT3 by
TC45 which subsequently results in the promotion of
apoptosis after UVB exposure.

Inhibition of TC45 nuclear translocation
suppressed
UVB-induced
apoptosis
in
keratinocytes
Studies have shown that STAT3 contributes
to enhanced skin cancer formation in UVB-induced
carcinogenesis by regulating its target gene expression
[35]. One of the major functions of STAT3 in skin
carcinogenesis is to inhibit apoptosis by upregulating
anti-apoptotic gene expression. Given that inhibition
of TC45 nuclear translocation results in the increase
of phosphorylated STAT3 expression following UVB
irradiation, we examined the impact of TC45 nuclear
translocation on UVB-induced apoptosis. We utilized low
dose UVB radiation in order to better observe the effect
of TC45-mediated cellular responses because high dose
UVB irradiation resulted in the rapid dephosphorylation
of STAT3 and higher doses of UVB resulted in severe
UVB-mediated damage that prevented cells from
recovering [17,18]. As shown in Figure 6A, there are no
morphological differences between TC45/WT-expressing
cells and TC45/T179A-overexpressing cells in the absence
of UVB. However, TC45/WT-expressing cells were more
sensitive to low dose UVB irradiation than TC45/T179Aoverexpressing cells as indicated by morphological
changes. TC45/WT-expressing cells showed profound
morphological changes induced by apoptosis, like
rounding, bleb formation, and nuclear shrinkage,
compared to TC45/T179A-overexpressing cells (Figure
6A). Consistent with this observation, flow cytometrybased apoptosis detection showed that the number of
Annexin-V-positive (apoptotic) cells was significantly
increased in UVB-treated TC45/WT-expressing cells
compared to TC45/T179A-overexpressing cells (Figure
6B) and this result corresponded with reduced cell
viability (Figure 6C). Western blot analysis showed that
while the level of Bcl-xL expression, an anti-apoptotic
protein regulated by STAT3, was reduced in TC45/WTexpressing cells 17 hours after low dose UVB irradiation,
its expression level was increased in TC45/T179Aoverexpressing cells in response to UVB (Figure 6D).
Conversely, the level of Bax expression, a pro-apoptotic
protein also regulated by STAT3, was clearly increased
in TC45/WT-expressing cells compared to TC45/T179Aoverexpressing cells after UVB irradiation. In addition,
the levels of the apoptotic markers cleaved Caspase-3 and
www.impactjournals.com/oncotarget

Inhibition of TC45 nuclear translocation
promotes UVB-induced keratinocyte proliferation
via STAT3 signaling
In addition to the regulation of cell survival, STAT3
contributes to UVB-induced skin cancer formation
by promoting cell proliferation [35]. We examined
the impact of TC45 nuclear translocation on low dose
UVB-induced cell proliferation. Cell viability of TC45/
T179A-overexpressing 3PC cells was unaffected by
low dose UVB irradiation as evidence by the fact that
cell viability for TC45/T179A-overexpressing cells was
significantly higher in comparison to control 3PC cells
(3PC/Mock) or TC45/WT-overexpressing 3PC cells and
cell viability increased over time (Figure 7A). 3PC cells
overexpressing TC45/WT showed significantly reduced
cell viability compared to control, indicating, again, that
TC45/WT-overexpressing cells are more susceptible to
low dose UVB-induced damage. Consistent with these
results, Western blot analysis showed that the levels of
cyclin D1 and c-Myc, STAT3 target proteins associated
with cell proliferation, were reduced in TC45/WToverexpressing cells after UVB irradiation compared to
TC45/T179A-overexpressing cells (Figure 7B), implying
that disruption of TC45 nuclear translocation prevents
STAT3 dephosphorylation by TC45 which results in
STAT3-mediated cell proliferation. To determine the
impact of STAT3 on enhanced cell proliferation observed
in TC45/T179A-overexpressing 3PC cells following
UVB irradiation, TC45/T179A-overexpressing cells
were treated with STAT3-specific inhibitors, STA-21
or S31-201, before UVB irradiation. Pretreatment with
either STA-21 or S3I-201 before UVB exposure reduced
the level of cyclin D1 expression in TC45/T179Aoverexpressing cells (Figure 7C). We also examined
keratinocyte viability in the presence of the STAT3
inhibitors. In the absence of UVB, treatment with either
STA-21 or S3I-201 significantly reduced cell viability in
both TC45/WT- and TC45/T179A-overexpressing cells
in comparison to DMSO-treated controls (Figure 7D).
Again, our results demonstrated that in the presence of
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Figure 6: Inhibition of TC45 nuclear translocation suppresses UVB-induced apoptosis in keratinocytes. A.. Representative

images of morphological changes of keratinocytes 17 h after UVB irradiation. 3PC cells overexpressing TC45/WT or TC45/T179A were
cultured and irradiated with UVB at a dose of 5 mJ/cm2. Scale bar: 20 μm. B. and C. Apoptosis response of TC45/WT- and TC45/T179Aoverexpressing cells in response to UVB irradiation. 3PC cells overexpressing TC45/WT or TC45/T179A were irradiated with UVB at
a dose of 5 or 10 mJ/cm2 and incubated for 17 h following UVB irradiation. Quantification of B. apoptotic cells stained with Annexin V
and FITC and C. viable cells stained with PI using flow cytometry. Results are the mean ± standard deviation from three independent
experiments. *p < 0.05 by T-test for Equality of Means. D. Western blot analysis of apoptosis-related proteins. 3PC cells overexpressing
TC45/WT or TC45/T179A were irradiated with UVB at a dose of 5 mJ/cm2 and incubated for 17 h following UVB irradiation. Total cell
lysates were isolated and resolved by SDS-PAGE and immunoblotted with antibodies specific for Bcl-xL, Bax, cleaved Caspase 3 (Cleaved
Cas3), or cleaved PARP. E. Cell cycle analysis. 3PC cells overexpressing TC45/WT or TC45/T179A were irradiated with UVB at a dose of
10 mJ/cm2 and incubated for 24 h following UVB irradiation. DNA content was quantified through flow cytometric analysis of PI stained
cells.
www.impactjournals.com/oncotarget
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Figure 7: Inhibition of TC45 nuclear translocation promotes UVB-induced keratinocyte proliferation via STAT3
signaling. A. Cell proliferation of TC45/WT- and TC45/T179A-overexpressing cells in response to UVB irradiation. 3PC cells
overexpressing TC45/WT or TC45/T179A were cultured and irradiated with UVB at a dose of 2 mJ/cm2. Cell proliferation was measured
by CCK-8 assay at the indicated times following UVB irradiation. Results are the mean percentage of viable cells normalized to untreated
control (0 h) ± standard deviation from three independent experiments. *p < 0.05 by T-test for Equality of Means. B. 3PC cells overexpressing
TC45/WT or TC45/T179A were irradiated with UVB at a dose of 5 mJ/cm2 and incubated for 30 min following UVB irradiation. Total cell
lysates were isolated and resolved by SDS-PAGE and immunoblotted with antibodies specific for pSTAT3, STAT3, Cyclin D1, or c-Myc.
C. Western blot analysis of pSTAT3, STAT3, Cyclin D1, or c-Myc expression in response to UVB irradiation. TC45/T179A-overexpressing
cells were incubated with STAT3 inhibitors, STA21 (5µM) or S3I-201 (25 µM), for 1 h before UVB irradiation (5 mJ/cm2). Cells were
incubated with inhibitor again for 30 min following UVB irradiation at which time total cell fractions were extracted. D. Effect of STAT3
inhibition on UVB-induced cell proliferation. TC45/WT- and TC45/T179A-overexpressing cells were incubated with STA21 (5 µM) or
S3I-201 (25 µM) for 1 h before UVB irradiation (2 mJ/cm2). Cell proliferation was measured by CCK-8 assay 24 h after UVB irradiation.
Results are the mean percentage of viable cells normalized to “Control” (DMSO-, UV-) ± standard deviation from three independent
experiments. *p < 0.05 by T-test for Equality of Means. E. Effect of STAT3 inhibition on cell viability of TC45/T179A-overexpressing
cells after UVB exposure. Cells were incubated with STA21 (5 µM) or S3I-201 (25 µM) for 1 h before UVB irradiation (5 mJ/cm2). Then,
cells were stained with crystal violet 48 h after UVB irradiation.
www.impactjournals.com/oncotarget
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UVB, cell viability of TC45/WT-overexpressing cells was
significantly reduced compared to untreated control cells,
and UVB irradiation had no effect on the viability of TC45/
T179A-overexpressing cells as there was no significant
change in cell viability of DMSO-treated control cells
upon UVB exposure. However, pretreatment with either
STA-21 or S3I-201 before UVB exposure significantly
reduced the viability of TC45/T179A-overexpressing cells
to a level comparable with that of UVB-treated TC45/WToverexpressing cells (Figure 7D). Crystal violet staining

of TC45/T179A-overexpressing cells also clearly showed
that treatment with STAT3-specific inhibitors dramatically
reduced cell viability 48 h after UVB irradiation compared
to untreated controls (Figure 7E).
Overall, our results indicate that UVB-induced
TC45 nuclear translocation by the AKT/14-3-3σ axis
allows for the dephosphorylation of STAT3, leading to
increased apoptosis and decreased cell proliferation of
keratinocytes, which can contribute to the prevention of
skin cancer development.

Figure 8: Schematic diagram of the mechanism of TC45 nuclear translocation in keratinocytes following UVB
irradiation. UVB irradiation triggers AKT activation which promotes nuclear translocation of TC45 with 14-3-3σ. AKT-mediated

phosphorylation of T179 within the catalytic domain of TC45 and the subsequent binding of 14-3-3σ at this site facilitate the translocation
of cytoplasmic TC45 to the nucleus upon UVB exposure. Once TC45 is translocated to the nucleus, it is capable of interacting with active
STAT3 to dephosphorylate it, resulting in the promotion of apoptosis and the inhibition of keratinocyte cell proliferation.
www.impactjournals.com/oncotarget
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DISCUSSION

in keratinocytes following UVB irradiation compared to
control (Figures 4A, 5E). Consistent with these results,
blocking TC45 nuclear translocation with the T179A
mutation also reduced UVB-induced apoptosis (Figure 6)
and promoted cell proliferation (Figure 7). These results
further demonstrate that subcellular localization and
translocation of PTPs are crucial for the regulation of their
cellular functions.
AKT is a serine/threonine kinase that is associated
with a variety of cancers given its ability to phosphorylate
proteins involved in cell survival, metabolism, and cell
cycle progression [49, 50]. In this regard, it has been
suggested that AKT is a critical oncogenic factor in
skin carcinogenesis [51]. Mice overexpressing either
epidermal specific AKT or constitutively active AKT
showed a significantly increased sensitivity to twostage skin carcinogenesis [52]. Recent studies also
showed that epidermal specific TC-PTP knockout mice
had a significantly increased sensitivity to two-stage
skin carcinogenesis which correlated with higher levels
of phosphorylated STAT3 and phosphorylated AKT
expression [16]. In addition, AKT activation induced by
UV irradiation has been shown to prevent cell death and
promote cell proliferation in the skin [53]. Our current
studies indicate that AKT plays a role in TC45-mediated
dephosphorylation of STAT3 through its ability to facilitate
TC45 translocation in response to UVB irradiation.
Inhibition of AKT prevented nuclear translocation of
TC45 and 14-3-3σ following UVB exposure (Figures 1E,
2E), leading to increased STAT3 phosphorylation, which
can contribute to the promotion of keratinocyte survival
and proliferation. Our results suggest that AKT can play
two roles in the keratinocyte response to UVB radiation:
(1) AKT can participate in a protective mechanism that
is triggered after initial exposure to UVB which initially
prohibits keratinocyte proliferation and survival [18]
to minimize potential UVB damage and (2) following
prolonged or excessive exposure to UVB radiation,
aberrant AKT activation can promote keratinocyte survival
and proliferation, leading to skin carcinogenesis. Since
TC45 can inhibit AKT signaling [16], it is possible that
once TC45 has been transported to the nucleus, a negative
feedback loop could arrest AKT-mediated TC45 nuclear
translocation. In this case, levels of phosphorylated STAT3
would recover, which we previously have observed [18],
and keratinocyte proliferation would proceed normally.
In conclusion, our findings provide a description
of a novel mechanism induced by UVB irradiation that
allows for TC45 nuclear translocation by the AKT/14-3-3σ
axis and that plays a significant part in an initial protective
mechanism against UVB exposure that allows for the
efficient removal of UVB-damaged cells by increasing
apoptosis and reducing cell proliferation through the
dephosphorylation of STAT3.

PTPs play important roles in various physiological
functions including growth, differentiation, apoptosis, and
motility by negatively regulating the rate and duration of
phosphotyrosine signaling [36, 37]. It has been recognized
that subcellular localization and translocation of PTPs
are critical in regulating their physiological functions
by making it possible to access their target substrates
[38]. Subcellular localization and translocation of PTPs
are regulated by their unique domains, such as NLS,
or by phosphorylation. For example, a non-receptor
form of PTPε is localized to the nucleus by its unique
N-terminal domain [39]. PTP36/PTPD2/Pez, one of the
non-transmembrane PTPs, is localized to the cytoplasm by
phosphorylation of its serine residues. Moreover, PTP36
is translocated from the cytoplasm to the cytoskeleton
by dephosphorylation [40]. TC45, a major form of TCPTP, has been reported to primarily localize to the nucleus
of cells by its bipartite NLS [19]. In contrast, our recent
studies showed keratinocyte-specific localization of TC45
in that TC45 is primarily localized in the cytoplasm of
keratinocytes and then is translocated from the cytoplasm
to the nucleus in response to UVB irradiation [16]. In the
current study, we describe a novel mechanism for TC45
nuclear translocation induced by UVB exposure. UVB
irradiation triggers AKT activation in keratinocytes. Then,
AKT-mediated phosphorylation of T179 in the catalytic
domain of TC45 and the subsequent direct interaction
of TC45 with 14-3-3σ promotes the translocation of
cytoplasmic TC45 to the nucleus in response to UVB
irradiation. Translocation of TC45 allows it to interact
with active/phosphorylated STAT3 in the nucleus and
dephosphorylate it, resulting in the promotion of UVBinduced apoptosis and the inhibition of keratinocyte cell
proliferation (Figure 8).
STAT3 is one of a family of cytoplasmic proteins
that participates in normal cellular responses to cytokines
and growth factors as a transcription factor. STAT3
modulates various physiological functions including
apoptosis, cell cycle regulation, and tumor angiogenesis
through regulation of gene expression, and its constitutive
activation is associated with a number of human epithelial
cancers [41-43]. Recent studies have shown that
activation of STAT3 might be a predominant factor in the
development of UVB-induced skin tumors by promoting
keratinocyte survival and proliferation [35, 44, 45]. TC45
has been reported to play a role in cell cycle regulation and
an Interleukin-6-mediated signaling pathway by targeting
STAT3 [46-48]. In contrast to other types of tissues, TC45
is primarily localized in the cytoplasm of keratinocytes
(Figure 1A, 1B). Our studies suggest that TC45 nuclear
translocation by the AKT/14-3-3σ axis is critical for the
regulation of STAT3 signaling. Inhibition of TC45 nuclear
translocation via T179A mutation or NLSII deletion
significantly increased the level of phosphorylated STAT3
www.impactjournals.com/oncotarget
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MATERIALS AND METHODS

expression clones and selected with puromycin. Wildtype human TC45 (referred to as hTC45/WT) cDNA from
pCMV-SPORT6-hTC45 (Open Biosystems) was amplified
by PCR and cloned into the lentivirus entry vector pEFENTR B. The entry vector containing hTC45/WT was
mutated using the QuikChange® site-directed mutagenesis
kit to generate an hTC45 mutant clone containing the
substitution T179A using site-specific mutant primers
(Table 1). Stable human HaCaT keratinocyte cell lines
overexpressing hTC45/WT or hTC45/T179A with V5
epitope tag were established by lentiviral transduction as
described above. Wild-type mouse TC48 (referred to as
TC48/WT) cDNA from pCMV-SPORT6-mTC48 (Open
Biosystems) was amplified by PCR and cloned into the
lentivirus entry vector pEF-ENTR B. A stable mouse 3PC
keratinocyte cell line overexpressing TC48/WT with V5
epitope tag was established by lentiviral transduction as
described.

Cell culture and UVB irradiation
Primary keratinocytes obtained from 2 day-old
neonates from wild-type FVB mice through a previously
described method [54] and were cultured in keratinocyte
growth medium containing 1% fetal bovine serum
(FBS) and 1% penicillin/streptomycin at 37 ̊C and
5% CO2. The 3PC mouse cell line is an immortalized,
benign keratinocyte cell line that was derived from adult
mouse primary keratinocytes after exposure in vitro to
7,12-dimethylbenz [a]anthracene and selection with high
Ca2+ medium [55]. 3PC cells were cultured in EMEM
without CaCl2 (Lonza) containing 0.03 mM Ca2+, 1%
FBS, 1% penicillin/streptomycin, 5 ng/ml EGF, 2.5 μg/
ml insulin, 5 μg/ml hydrocortison, 10 μg/ml transferrin,
10 μM ethanolamine, and 10 μM phosphoethanolamine.
HaCaT keratinocytes (CLS-300493, CLS Cell Lines
Service GmbH, Eppelheim, Germany; immortalized and
nontumorigenic human skin keratinocyte cell line) [56]
were cultured in DMEM containing 10% FBS and 1%
penicillin/streptomycin at 37 ̊C and 5% CO2. Keratinocyte
cell lines were verified by consistent morphological
characteristics and used within 5 passages for experiments.
Keratinocytes were cultured to 80 - 85% confluence, at
which time cells were washed with DPBS. A small volume
of DPBS was added to coat keratinocytes with a thin layer
of DPBS, and then keratinocytes were irradiated with
UVB. Immediately after irradiation, DPBS was removed,
and prewarmed medium was added to cells for additional
culture time before harvest.

Antibodies and inhibitors
The antibodies against TC-PTP (TC45, #58935),
pSTAT3 (Y705) (#9145), STAT3 (#9139), pAKT (S473)
(#4060), AKT (#4685), Phospho-AKT substrate (#9614),
Bcl-xL (#2764), Bax (#2772), Cleaved Caspase 3 (#9661),
Cleaved PARP (#9548), Cyclin D1 (2978) and α/β tubulin
(#2148) were purchased from Cell Signaling Technology.
The antibodies against Lamin A/C (sc-7293), c-Myc (sc40), β-actin (sc-47778), and LDH (sc-33781) were bought
from Santa Cruz Biotechnology. The antibody against
14-3-3σ (GTX100801) was purchased from GeneTex.
Anti-V5 tag antibody (R960-25) was purchased from
Invitrogen and used for detection of exogenous TC45.
STA-21, S3I-201, AKT1/2 inhibitor, Staurosporine,
Gö6983, Ro-31-8220, Gö6976, spermidine, protease
inhibitor cocktail, phosphatase inhibitor cocktail I,
phosphatase inhibitor cocktail II and Leptomycin B were
purchased from Sigma-Aldrich.

Establishment of TC-PTP or mutant TC-PTP
overexpressing 3PC cell lines
Stable mouse 3PC keratinocyte cell lines
overexpressing TC45 mutants (referred to as TC45/
S173A, TC45/T179A, TC45/T225A, TC45/Q345A, or
TC45/Δ372) with a V5 epitope tag at the C-terminus were
established by lentiviral transduction using the lentivirus
entry vector pEF-ENTR B (Addgene plasmid #17428) and
the destination vector pLenti X1 Puro DEST (Addgene
plasmid #17297) [57]. The entry vector overexpressing
mouse TC45 (referred to as TC45/WT) [18] was mutated
using the QuikChange® site-directed mutagenesis kit
(Stratagene) to generate each of the TC45 mutants using
corresponding site-specific mutant primers (Table 1).
Gateway® LR Clonase® enzyme mix (Invitrogen) was used
to catalyze an LR recombination reaction between the
entry vectors expressing TC45 mutants and the destination
vector to generate the final lentiviral expression clones
for TC45 mutants, respectively. Then, 3PC keratinocytes
were infected with lentiviral particles from the lentiviral
www.impactjournals.com/oncotarget

Immunoblot analysis
Total cell lysates were prepared with RIPA Buffer
(Pierce) containing 1% Triton X-100, protease inhibitor
cocktail, and phosphatase inhibitor cocktail I and II
(Sigma-Aldrich). Equal amounts of total protein were
resolved using SDS-PAGE and subsequently transferred
to PVDF membrane (GE Healthcare). The membrane
was incubated overnight with primary antibody followed
by incubation with a horseradish peroxidase-conjugated
secondary antibodies. Chemiluminescent detection
reagents (Pierce) were used to detect immunoreactive
protein.
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Table 1: Oligonucleotide primers for site-directed mutagenesis of TC45
Target
mutation site

Oligonucleotide pimers

Substitution

Amino acid

Sequence (5'→3')

Single letter
Amino acid code

Species

Clone name

Human

TC45/T179A

179

Mouse

TC45/S173A

173

Mouse

TC45/T179A

179

Mouse

TC45/T225A

225

Mouse

TC45/R345Q

345, 346, 347

Mouse

TC45/Δ372

372-376

Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

cca gaa caa tat ctc act ttc att ata ctg cct ggc cag att ttg
caa aat ctg gcc agg cag tat aat gaaa gtg aga tat tgt tct gg
ctg gtg aaa cca gaa cca tag ccc act tcc att ata cca cct
agg tgg tat aat gga agt ggg cta tgg ttc tgg ttt cac cag
ata tct cac ttc cat tat acc gcc tgg cca gat ttt gg
cca aaa tct ggc cag gcg gta taa tgg aag tga gat at
cgg gcg ctc tgg cgc ctt ctc tct tgt
aca aga gag aag gcg cca gag cgc ccg
gga gag cag tga gag cat tct aca gca aca gat tcg aga gga tag aaa ggc tac
gta gcc ttt cta tcc tct cga atc tgt tgc tgt aga atg ctc tca ctg ctc tcc
cag agg cta aat gaa act gaa cca aga ttg aca gac acc
ggt gtc tgt caa tct tgg ttc agt ttc att tag cct ctg

Immunoprecipitation analysis

S173 → A173
T179 → A179
T225 → A225
R345Q; K346Q; R347Q
D372-376: deletion

was performed three times, and data were presented as
means ± standard deviation. For cell cycle analysis, cells
were exposed to UVB (5 mJ/cm2). Twenty four hours after
UVB irradiation, cells were collected and fixed with 70%
ethanol. After washing twice with cold PBS, cells were
stained with propidium iodide. All of the resulting data
was produced and analyzed using Flowjo V10.2 software.

Total cell lysates were prepared with Nonidet
P-40-containing immunoprecipitation buffer (40 mM
Tris, pH 7.4, 120 mM NaCl, 10 mM EDTA, 0.1% (v/v)
Nonidet P-40) containing protease inhibitor mixture,
and phosphatase inhibitor cocktail I and II. Prior to
immunoprecipitation, antibodies are incubated with
magnetic DynabeadsTM Protein G (Invitrogen) and
then 2 mg of protein lysates was added into V5-attached
magnetic beads and incubated overnight at 4 °C. After
immunoprecipitation, the beads were washed three times
with washing buffer and then the immune complexes were
eluted from the beads and subjected to SDS-PAGE and
immunoblot analysis as previously described.

Cell proliferation assay
Keratinocyte proliferation was assessed by the Cell
Counting Kit-8 (Dojindo Laboratories) colorimetric assay
according to the manufacturer’s instructions. Briefly,
keratinocytes were plated at a density of 2 x 103 ~ 2 x 104
cells/well in 96-well cell culture plates. Then, cells were
irradiated by UVB as described above and recultured for
24 - 72 h. Then, the formazan dye was added to each well
and absorbance was read at 450 nm.

RNA interference (RNAi)
3PC keratinocytes were grown overnight to
~40% confluence and transfected with control siRNA
or 14-3-3σ-specific siRNA (Santa Cruz Biotechnology).
Transfection was performed with Lipofectamine
RNAiMAX (Invitrogen) according to the manufacturer’s
instructions.

Crystal violet staining
Cells (1 x 105 cells/well) were cultured in the
presence of STAT3 inhibitors STA-21 or S3I-201 for 1
h before UVB irradiation (5 mJ/cm2). Following UVB
irradiation, cells were incubated for 48 h and then stained
with 0.05% crystal violet.

Flow cytometric analysis for apoptosis and cell
cycle

Immunocytochemical analysis

Apoptosis of keratinocytes was assessed by an
Annexin V-FITC apoptosis kit (Molecular probe, V13242)
according of the manufacturer’s instructions. Briefly, cells
(1 x 106) were collected at 17 h after UVB irradiation (5
or 10 mJ/cm2). Cells were then washed with cold PBS and
centrifuged at 400 x g for 5 min and stained using Annexin
V-FITC. Then, cell suspensions were analyzed using
LSRFortessa (BD Biosciences). The apoptotic rate was
calculated as Annexin V-positive cells. Each experiment
www.impactjournals.com/oncotarget

T179 → A179

Cells (5 x 104 cells/well) were seeded on an IbiTreat
30 µ-Dish culture plate (ibidi, GmbH). The following
day, cells were irradiated with UVB and recultured for
3 h. Cells were then fixed with 4% paraformaldehyde
for 15 min. Cells were washed with cold PBS and then
incubated with 0.02% Triton X-100 for 20 min. After
being washed again with PBS, cells were incubated with
background sniper (Biocare Medical) for 1 h. Then,
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cells were incubated with an anti-V5 tag antibody for
detection of exogenous TC45 or anti-14-3-3σ antibody
and washed with PBS. Cells were incubated with Alexa
Fluor 488 or 647-conjugated secondary antibodies and
washed with PBS. Slides were rinsed with PBS, mounted
in VECTASHIELD Mounting Medium for fluorescence
with DAPI (Vector Laboratories, H-1200) and sealed with
clear nail varnish. Images were taken by fluorescence
microscopy.
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